No job is too big or too small: leading with passion and inspiring better outcomes
Dr. Florian Kuchenbauer receives a BC Cancer Excellence Award in the category of Patient Care Champion, nominated by patients.
Dr. Florian Kuchenbauer receives Michael Smith Health Research BC Health Professional-Investigator (HP-I) Award
Dr. Kuchenbauer aims to better understand the energy metabolism of high-risk acute myeloid leukemia cells and explore this as a novel treatment avenue.
BC Cancer researchers Dr. Peter Stirling and Dr. David Huntsman awarded OvCAN/Ovarian Cancer Canada-Cancer Research Society Grant
Dr. Peter Stirling (Stirling Lab) and co-principal investigators Dr. David Huntsman (Huntsman Lab), Philip Hieter (UBC) and Jean-Yve Masson (Laval University) were awarded a 2021 OvCAN/Ovarian Cancer Canada-Cancer Research Society Grant for their research entitled, “Next generation DNA repair inhibitors for ovarian cancer treatment.”
Pamela Hoodless awarded Cancer Research Society Operating Grant
Congratulations to Pamela Hoodless for receiving a Cancer Research Society Operating Grant for her project entitled, “Defining epigenetic alterations in liver cancer at single cell resolution”.
Dr. Florian Kuchenbauer receives funding for multiple myeloma clinical projects aiming to improve treatment outcomes
Congratulations to Dr. Kuchenbauer for receiving $50,000 USD in Proteona’s ESCAPE™ multi-omic single cell analysis services.
Drs. Florian Kuchenbauer and Kevin Hay receive grants from International Myeloma Society and Paula and Rodger Riney Foundation
The goal of these grants is to foster and support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment.
Terry Fox Laboratory
Making novel discoveries in the biology underlying normal development and cancer progression.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.